Wir sind mit live!
Mehr erfahren
Virtus Biotech Clinical Trials ETF
| Name | Position | Handelswert |
Veränderung Aktien |
Anteils- änderung |
|
|---|---|---|---|---|---|
1
Goldman Sachs
New York
| 3,62 Mio. $ | -3,44 Mio. $ | -100.000 | -50 % |
|
2
Jane Street
New York
| 2,07 Mio. $ | +1,37 Mio. $ | +39.905 | +232 % |
|
3
Virtu KCG Holdings
New York
| 1,13 Mio. $ | +1,08 Mio. $ | +31.275 | Neu |
|
4
LPL Financial
San Diego,
California
| 897.000 $ | +191.533 $ | +5.571 | +29 % |
|
5
Credit Suisse
Zurich,
Switzerland
| 511.000 $ | -5.329 $ | -155 | -1 % |
|
6
Baker Avenue Asset Management
San Francisco,
California
| 254.000 $ | -38.162 $ | -1.110 | -14 % |
|
7
Ladenburg Thalmann Financial Services
Miami,
Florida
| 80.000 $ | +75.637 $ | +2.200 | Neu |
|
8
UBS Group
Zurich,
Switzerland
| 31.000 $ | +21.453 $ | +624 | +267 % |
|
|
AIG
9
American International Group
New York
| 9.055 $ | +8.595 $ | +250 | Neu |
|
10
Morgan Stanley
New York
| 3.000 $ | -3.438 $ | -100 | -59 % |
|
11
Tower Research Capital (TRC)
New York
| – | -53.840 $ | -1.566 | -100 % |
|
12
MassMutual Private Wealth & Trust
Windsor,
Connecticut
| – | -8.143 $ | -248 | Geschlossen |
|
13
Creative Planning
Overland Park,
Kansas
| – | -7.000 $ | -200 | Geschlossen |
|